Stock listing

Frankfurt:J4I Solvonis Therapeutics PLC Aktie

German listing (Frankfurt) of Solvonis Therapeutics PLC · home listing LSE:SVNS

Follow Solvonis Therapeutics PLC into a list and get an email when it puts out news.

Share price · FWB:J4I

€0.0010 EUR 0.0000 (0.0%)

Close on Oct 30, 2026

Day range
€0.0010 – €0.0010 EUROct 30, 2026
Market cap
€7.90M EURAt the close on Oct 30, 2026 · price × 7.90B shares outstanding
Solvonis Therapeutics PLC logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
LSE:SVNS · Home0.095p GBX (pence)0.000 (0.0%)86,009,9290.098p0.100p0.091p0.095pClose on Nov 2, 2026
OTC:SLVNF$0.0008 USD—11,200$0.0008$0.0012$0.0008—Close on Oct 21, 2026
Frankfurt:J4I€0.0010 EUR0.0000 (0.0%)—€0.0010€0.0010€0.0010€0.0010Close on Oct 30, 2026
Ticker
Frankfurt:J4I
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

All Solvonis Therapeutics PLC news

Financings

  • Private placement of new Ordinary Shares

    Aug 25, 2026 · US$1.77M

    Announced: £1.3M · £0.0012 a share · Turner Pope Investments (TPI) Limited

    Dealers: Turner Pope Investments (TPI) Limited (lead)

    Use of proceeds: Adding international sites to SVN-001 Phase 3, advancing SVN-002 towards US IND and Phase 2b, progressing SVN-015 with NIDA, and working capital

    Announced Aug 25, 2026

Read by 6ix AI from the company's releases

Decks

Solvonis Therapeutics PLC on 6ix

Sector
Health care
Industry
Biotechnology
News releases
24 in the last 12 months · 118 in all · newest Oct 30, 2026 · oldest 2022
Decks
3 decks · latest Oct 13, 2026

Where Solvonis Therapeutics PLC is listed

ListingExchangeCountryCurrency
LSE:SVNS · Home listingLSEUnited KingdomGBX
OTC:SLVNFOTCUnited StatesUSD
LS Exchange:A3DCC0LS ExchangeGermanyEUR
Lang & Schwarz:A3DCC0Lang & SchwarzGermanyEUR
gettex:J4IgettexGermanyEUR
Frankfurt:J4I · This pageFrankfurtGermanyEUR
Munich:J4IMunichGermanyEUR
Stuttgart:J4IStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Solvonis Therapeutics PLC.